Charlson Comorbidity Index And Quality Of Life In Chronic Dialysed Patients

Dr. Nitoi Luciana Carmen; Dr. Luciana Carmen Nitoi

Volume : VIII, Issue : XII, December - 2019

Charlson Comorbidity Index And Quality Of Life In Chronic Dialysed Patients

Dr. Nitoi Luciana Carmen, Dr. Luciana Carmen Nitoi

Abstract :

Aim: Many patients with end–stage renal disease have additional comorbidities that are important to clinical study and impact the patient‘s outcome. The Charlson Comorbidity Index (CCI) is a popular tool and a strong predictor of outcome in end–stage renal disease patients. We obtained comorbidity data from the dialysis unit discharge database and analysed the CCI impact on QoL of patients undergoing dialysis therapy. Material and methods: We evaluated the medical records of a total of 254 patients on chronic dialysis therapy: 243 patients undergoing maintenance hemodialysis (HD) and 11 patients on peritoneal dialysis (PD). The outcome of interest was health related quality of life (HRQOL), which was measured using the Kidney Disease Quality of Life–Short Form (KDQOL–SF–36). We calculated CCI scores at the start of HD with information from the hospital discharge summary and analysed the influence of Charlson Comorbidity Index on QoL of chronic dialysed patients. Results: Our study has found a CCI in a range of 2–9 points. We did not recorded a significant difference between HD and DP group (Chi–square = 8.604, p = 0.282). HRQOL was significantly lower for patients who had more comorbid disease. Conclusions: The CCI scores recorded a significant negative impact on QoL in patients undergoing maintenance HD.